Loading clinical trials...
Loading clinical trials...
In this study, the researchers propose to investigate the efficacy of inhaled nitric oxide to prevent ischemia-reperfusion (I/R) hepatocyte injury in patients who receive extended donor criteria(EDC)l...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation
NCT07269041 · Liver Transplantation, Immune Tolerance, and more
NCT05428267 · Sexual Dysfunction in Patients With Cirrhosis Awaiting Liver Transplantation
NCT07233096 · Liver Transplantation, Living Donor, and more
NCT07301853 · Living Donor Liver Transplantation Recipients, Deceased Donor Liver Transplantation Recipients, and more
University of Colorado Hospital
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions